Topotecan Episcleral Plaque for Treatment of Retinoblastoma
Clinical trial NCT04156347 · UNKNOWN
Trial details
- NCT number
- NCT04156347
- Sponsor
- Targeted Therapy Technologies, LLC
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-16
- Primary completion
- 2024-10-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.